🇺🇸 FDA
Patent

US 6610660

O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates

expired A61PA61P11/00A61P15/10

Quick answer

US patent 6610660 (O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61P, A61P11/00, A61P15/10, A61P29/00, A61P31/00